Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne
Clinical trial NCT03497897 · COMPLETED
Trial details
- NCT number
- NCT03497897
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2022-02-24
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.